- Home
- SRRK vs CC Comparison
SRRK vs CC Comparison
Compare SRRK & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- CC
- Stock Information
- Founded
- SRRK 2012
- CC 2014
- Country
- SRRK United States
- CC United States
- Employees
- SRRK N/A
- CC N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- CC Major Chemicals
- Sector
- SRRK Health Care
- CC Industrials
- Exchange
- SRRK Nasdaq
- CC Nasdaq
- Market Cap
- SRRK 3.3B
- CC 2.9B
- IPO Year
- SRRK 2018
- CC N/A
- Fundamental
- Price
- SRRK $32.15
- CC $13.54
- Analyst Decision
- SRRK Strong Buy
- CC Buy
- Analyst Count
- SRRK 7
- CC 9
- Target Price
- SRRK $40.43
- CC $22.89
- AVG Volume (30 Days)
- SRRK 1.1M
- CC 4.0M
- Earning Date
- SRRK 05-06-2025
- CC 05-26-2025
- Dividend Yield
- SRRK N/A
- CC 7.39%
- EPS Growth
- SRRK N/A
- CC N/A
- EPS
- SRRK N/A
- CC 0.57
- Revenue
- SRRK N/A
- CC $5,782,000,000.00
- Revenue This Year
- SRRK N/A
- CC $4.60
- Revenue Next Year
- SRRK $601.05
- CC $4.43
- P/E Ratio
- SRRK N/A
- CC $23.75
- Revenue Growth
- SRRK N/A
- CC N/A
- 52 Week Low
- SRRK $6.76
- CC $13.09
- 52 Week High
- SRRK $46.98
- CC $29.21
- Technical
- Relative Strength Index (RSI)
- SRRK 36.26
- CC 37.22
- Support Level
- SRRK $31.60
- CC $13.70
- Resistance Level
- SRRK $33.96
- CC $14.72
- Average True Range (ATR)
- SRRK 1.62
- CC 0.60
- MACD
- SRRK -0.02
- CC 0.08
- Stochastic Oscillator
- SRRK 20.86
- CC 15.12
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About CC Chemours Company (The)
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.